Dr. Lal Pathlabs shares hit 52-week low post Q4 results; here’s why Dr. Lal Pathlabs has reported a 27% YoY fall in consolidated net profit to ₹62 crore in Q4FY22 due to a decline in revenue from Covid and allied business. By Chitranjan Kumar
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
